Published within
| Type |
Product title / description
|
Pub
|
Price |
Company Profile
|
ALK-Abello (or 'the group') is a Denmark-based pharmaceutical group engaged in the development and marketing of allergy treatment products. The group operates in Europe, the US, Canada, China and other parts of the world. It is headquartered in Horsholm, Denmark, and employed 1,724 people as of December 31, 2011.
Published By MarketLine
|
25 Jan 2013 |
$175
|
Company Profile
|
AstraZeneca PLC (AstraZeneca or 'the company') is a UK-based global biopharmaceutical company. The company is engaged in developing, manufacturing, and marketing prescription pharmaceuticals in the area of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, inflammation, and infection. AstraZeneca operates in the Americas, Europe and Asia. The company is headquartered in London, the UK and employed about 59,800 people as of December 31, 2011.
Published By MarketLine
|
31 Jul 2012 |
$175
|
Company Profile
|
Boehringer Ingelheim (BI or 'the group') is a privately-held pharmaceuticals and animal health business group. BI, through its subsidiaries, is engaged in the research, development, manufacture and marketing of branded and generic prescription drugs, consumer health care products, and animal health products. The group operates in Europe, the Americas, Asia, Australia and Africa. It is headquartered in Ingelheim, Germany. For 2011, the group's average number of employees was 44,094.
Published By MarketLine
|
13 Dec 2012 |
$175
|
Company Profile
|
Elan Corporation, plc (Elan or 'the company') is a neuroscience-based biotechnology company focusing on the discovery, development, manufacture and marketing of therapies in neuroscience, autoimmune diseases, and severe chronic pain. Elan's flagship product, Tysabri (natalizumab), is being marketed in collaboration with Biogen Idec for the treatment of multiple sclerosis and Crohn's disease. The company primarily operates in the US and Ireland. Elan is headquartered in Dublin, Ireland and employed 412 people...
Published By MarketLine
|
30 Oct 2012 |
$175
|
Company Profile
|
F. Hoffmann-La Roche Ltd (Roche or 'the group') is one of the leading research-focused healthcare groups in the world. It is engaged in the discovery, development and commercialization of innovative diagnostic and therapeutic products. Roche is headquartered in Basel, Switzerland, and employed 80,129 people as of December 31, 2011.
Published By MarketLine
|
20 Jul 2012 |
$175
|
Company Profile
|
Gedeon Richter (or 'the group') is engaged in the research, development and production of pharmaceutical products. The group is also involved in the wholesale and retail marketing of these products. The group operates in Hungary, other European Union (EU) countries, the US, and the Commonwealth of Independent States (CIS). Gedeon Richter is headquartered in Budapest, Hungary, and employed 10,773 people as of December 31, 2011.
Published By MarketLine
|
23 Nov 2012 |
$175
|
Company Profile
|
GlaxoSmithKline Plc (GSK or 'the company') is a leading global provider of pharmaceutical and consumer health-related products. The company operates in 120 countries and its products are sold in more than 150 countries. GSK is headquartered in Brentford, the UK and employed 97,389 people as of December 31, 2011.
Published By MarketLine
|
30 Oct 2012 |
$175
|
Company Profile
|
Ipsen (or 'the group') is a global biopharmaceutical group with products in targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. The group operates in Europe, North America and other parts of the world. It is headquartered in Boulogne-Billancourt, France and employed 4,479 people as of December 31, 2011.
Published By MarketLine
|
19 Nov 2012 |
$175
|
Company Profile
|
Les Laboratoires Servier (Servier or 'the company') is the leading independent pharmaceutical company in France. The company focuses primarily in the therapeutic areas of neurosciences, oncology, cardiovascular disease, metabolic disease, rheumatology, and basic research. The company operates in 140 countries. It is headquartered in Neuily-Sur-Seine, France, and employs about 20,000 people.
Published By MarketLine
|
03 Oct 2012 |
$175
|
Company Profile
|
The Menarini Group (Menarini or 'the group') is a leading privately-held pharmaceutical player in Italy. The group is engaged in the development and manufacture of pharmaceutical products mainly for cardiovascular diseases, oncology, and pain, inflammation and asthma. Menarini has established its presence throughout Europe, Latin America, Asia, and Africa. The group is headquartered in Florence, Italy and employed 15,993 people at the end of the year 2011.
Published By MarketLine
|
26 Nov 2012 |
$175
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.